Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Stabilisation Notice

31 Oct 2018 09:06

RNS Number : 8441F
GoldmanSachs International
31 October 2018
 

Form of Stabilisation Notice to the Market

To the market

31 October 2018

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Aston Martin Lagonda Global Holdings plc

Goldman Sachs International (contact: John Bentinck; telephone: 44207-7743408) hereby gives notice that stabilisation was undertaken in relation to the offer of Aston Martin as set out below.

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

 

Execution Date

Lowest Price

Highest Price

Trading Venue

23 October 2018

13.89

14.35

LNSE

24 October 2018

13.714

14.316

LNSE

25 October 2018

13.802

14.356

LNSE

26 October 2018

14.062

14.498

LNSE

29 October 2018

14.018

14.502

LNSE

 

This announcement is for information purposes only and does not constitute an offer or invitation to underwrite, subscribe for or otherwise acquire or dispose of any securities or investment advice in any jurisdiction in which such an offer or solicitation is unlawful, including without limitation, the United States, Australia, Canada or Japan. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

 

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933, as amended and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAEANEFDEAPFEF
Date   Source Headline
22nd Apr 20204:35 pmRNSPrice Monitoring Extension
21st Apr 20209:00 amRNSHolding(s) in Company
21st Apr 20209:00 amRNSHolding(s) in Company
21st Apr 20209:00 amRNSHolding(s) in Company
20th Apr 20209:18 amRNSAnnouncement re: Rights Issue
20th Apr 20207:05 amRNSStatement from Executive Chairman, Lawrence Stroll
20th Apr 20207:00 amRNSAnnouncement re: Rights Issue
17th Apr 20202:25 pmRNSHolding(s) in Company
17th Apr 20202:17 pmRNSHolding(s) in Company
17th Apr 20202:14 pmRNSHolding(s) in Company
17th Apr 20202:12 pmRNSHolding(s) in Company
8th Apr 20204:36 pmRNSPrice Monitoring Extension
8th Apr 202010:00 amRNSHolding(s) in Company
8th Apr 20209:00 amRNSAston Martin announces Interim CFO appointment
3rd Apr 20208:15 amRNSSuccessful private placement of nil paid rights
1st Apr 20203:45 pmRNSHolding(s) in Company
1st Apr 20203:45 pmRNSHolding(s) in Company
1st Apr 20203:10 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSAdditional Listing
31st Mar 20207:00 amRNSAdditional Listing
30th Mar 20205:21 pmRNSAnnouncement re: Rights Issue
30th Mar 20205:19 pmRNSResult of Meeting
24th Mar 20201:05 pmRNSUpdate on operations and the impact of COVID-19
17th Mar 20204:40 pmRNSSecond Price Monitoring Extn
17th Mar 20204:35 pmRNSPrice Monitoring Extension
17th Mar 20202:40 pmRNSAnnual Financial Report
13th Mar 20204:36 pmRNSAnnouncement re: Rights Issue
12th Mar 20204:45 pmRNSSecond Price Monitoring Extn
12th Mar 20204:40 pmRNSPrice Monitoring Extension
28th Feb 202010:00 amRNSTotal Voting Rights
27th Feb 20202:31 pmRNSPublication of a Prospectus
27th Feb 20207:00 amRNSAnnouncement re: Rights Issue
27th Feb 20207:00 amRNSDirectorate Change
27th Feb 20207:00 amRNSFinal Results
21st Feb 202011:49 amRNSHolding(s) in Company
21st Feb 202011:31 amRNSHolding(s) in Company
17th Feb 202011:28 amRNSHolding(s) in Company
17th Feb 202011:26 amRNSHolding(s) in Company
17th Feb 202011:22 amRNSHolding(s) in Company
17th Feb 202011:18 amRNSHolding(s) in Company
14th Feb 20203:26 pmRNSDirector/PDMR Shareholding
11th Feb 20203:12 pmRNSDirector/PDMR Shareholding
11th Feb 20203:11 pmRNSHolding(s) in Company
11th Feb 20203:09 pmRNSHolding(s) in Company
11th Feb 20203:05 pmRNSHolding(s) in Company
10th Feb 20204:07 pmRNSPassing Away of Non-Executive Director
31st Jan 20207:00 amRNSIssue of Equity
30th Jan 202010:52 amRNSTotal Voting Rights
7th Jan 20206:01 pmRNSTrading Statement - Clarification
7th Jan 20207:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.